These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 23531552

  • 1. Long-term follow-up of foamy viral vector-mediated gene therapy for canine leukocyte adhesion deficiency.
    Bauer TR, Tuschong LM, Calvo KR, Shive HR, Burkholder TH, Karlsson EK, West RR, Russell DW, Hickstein DD.
    Mol Ther; 2013 May; 21(5):964-72. PubMed ID: 23531552
    [Abstract] [Full Text] [Related]

  • 2. Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors.
    Bauer TR, Allen JM, Hai M, Tuschong LM, Khan IF, Olson EM, Adler RL, Burkholder TH, Gu YC, Russell DW, Hickstein DD.
    Nat Med; 2008 Jan; 14(1):93-7. PubMed ID: 18157138
    [Abstract] [Full Text] [Related]

  • 3. Treatment of canine leukocyte adhesion deficiency by foamy virus vectors expressing CD18 from a PGK promoter.
    Bauer TR, Olson EM, Huo Y, Tuschong LM, Allen JM, Li Y, Burkholder TH, Russell DW.
    Gene Ther; 2011 Jun; 18(6):553-9. PubMed ID: 21228879
    [Abstract] [Full Text] [Related]

  • 4. Gene therapy of canine leukocyte adhesion deficiency using lentiviral vectors with human CD11b and CD18 promoters driving canine CD18 expression.
    Hunter MJ, Tuschong LM, Fowler CJ, Bauer TR, Burkholder TH, Hickstein DD.
    Mol Ther; 2011 Jan; 19(1):113-21. PubMed ID: 20859258
    [Abstract] [Full Text] [Related]

  • 5. Gene therapy for canine leukocyte adhesion deficiency with lentiviral vectors using the murine stem cell virus and human phosphoglycerate kinase promoters.
    Hunter MJ, Zhao H, Tuschong LM, Bauer TR, Burkholder TH, Persons DA, Hickstein DD.
    Hum Gene Ther; 2011 Jun; 22(6):689-96. PubMed ID: 21275758
    [Abstract] [Full Text] [Related]

  • 6. Correction of the disease phenotype in canine leukocyte adhesion deficiency using ex vivo hematopoietic stem cell gene therapy.
    Bauer TR, Hai M, Tuschong LM, Burkholder TH, Gu YC, Sokolic RA, Ferguson C, Dunbar CE, Hickstein DD.
    Blood; 2006 Nov 15; 108(10):3313-20. PubMed ID: 16868255
    [Abstract] [Full Text] [Related]

  • 7. Preclinical Evaluation of Foamy Virus Vector-Mediated Gene Addition in Human Hematopoietic Stem/Progenitor Cells for Correction of Leukocyte Adhesion Deficiency Type 1.
    Smith RH, Bloomer H, Fink D, Keyvanfar K, Nasimuzzaman M, Sancheznieto F, Dutta R, Guenther Bui K, Alvarado LJ, Bauer TR, Hickstein DD, Russell DW, Malik P, van der Loo JCM, Highfill SL, Kuhns DB, Pirooznia M, Larochelle A.
    Hum Gene Ther; 2022 Dec 15; 33(23-24):1293-1304. PubMed ID: 36094106
    [Abstract] [Full Text] [Related]

  • 8. Lentiviral vectors incorporating a human elongation factor 1alpha promoter for the treatment of canine leukocyte adhesion deficiency.
    Nelson EJ, Tuschong LM, Hunter MJ, Bauer TR, Burkholder TH, Hickstein DD.
    Gene Ther; 2010 May 15; 17(5):672-7. PubMed ID: 20164857
    [Abstract] [Full Text] [Related]

  • 9. Potential genotoxicity from integration sites in CLAD dogs treated successfully with gammaretroviral vector-mediated gene therapy.
    Hai M, Adler RL, Bauer TR, Tuschong LM, Gu YC, Wu X, Hickstein DD.
    Gene Ther; 2008 Jul 15; 15(14):1067-71. PubMed ID: 18369320
    [Abstract] [Full Text] [Related]

  • 10. Retroviral-mediated gene transfer of the leukocyte integrin CD18 into peripheral blood CD34+ cells derived from a patient with leukocyte adhesion deficiency type 1.
    Bauer TR, Schwartz BR, Liles WC, Ochs HD, Hickstein DD.
    Blood; 1998 Mar 01; 91(5):1520-6. PubMed ID: 9473215
    [Abstract] [Full Text] [Related]

  • 11. Nonmyeloablative hematopoietic stem cell transplantation corrects the disease phenotype in the canine model of leukocyte adhesion deficiency.
    Bauer TR, Gu YC, Tuschong LM, Burkholder T, Bacher JD, Starost MF, Donahue RE, Sokolic RA, Hickstein DD.
    Exp Hematol; 2005 Jun 01; 33(6):706-12. PubMed ID: 15911095
    [Abstract] [Full Text] [Related]

  • 12. Very low levels of donor CD18+ neutrophils following allogeneic hematopoietic stem cell transplantation reverse the disease phenotype in canine leukocyte adhesion deficiency.
    Bauer TR, Creevy KE, Gu YC, Tuschong LM, Donahue RE, Metzger ME, Embree LJ, Burkholder T, Bacher JD, Romines C, Thomas ML, Colenda L, Hickstein DD.
    Blood; 2004 May 01; 103(9):3582-9. PubMed ID: 14715622
    [Abstract] [Full Text] [Related]

  • 13. Conversion of the severe to the moderate disease phenotype with donor leukocyte microchimerism in canine leukocyte adhesion deficiency.
    Gu YC, Bauer TR, Sokolic RA, Hai M, Tuschong LM, Burkholder T, Bacher J, Starost MF, Hickstein DD.
    Bone Marrow Transplant; 2006 Mar 01; 37(6):607-14. PubMed ID: 16444276
    [Abstract] [Full Text] [Related]

  • 14. Nonmyeloablative conditioning with busulfan before matched littermate bone marrow transplantation results in reversal of the disease phenotype in canine leukocyte adhesion deficiency.
    Sokolic RA, Bauer TR, Gu YC, Hai M, Tuschong LM, Burkholder T, Colenda L, Bacher J, Starost MF, Hickstein DD.
    Biol Blood Marrow Transplant; 2005 Oct 01; 11(10):755-63. PubMed ID: 16182176
    [Abstract] [Full Text] [Related]

  • 15. Efficiency of different fragment lengths of the ubiquitous chromatin opening element HNRPA2B1-CBX3 in driving human CD18 gene expression within self-inactivating lentiviral vectors for gene therapy applications.
    Gopinath C, Chodisetty S, Ghosh A, Nelson EJR.
    Gene; 2019 Aug 20; 710():265-272. PubMed ID: 31200085
    [Abstract] [Full Text] [Related]

  • 16. Stem cell selection in vivo using foamy vectors cures canine pyruvate kinase deficiency.
    Trobridge GD, Beard BC, Wu RA, Ironside C, Malik P, Kiem HP.
    PLoS One; 2012 Aug 20; 7(9):e45173. PubMed ID: 23028826
    [Abstract] [Full Text] [Related]

  • 17. Tracking of specific integrant clones in dogs treated with foamy virus vectors.
    Ohmine K, Li Y, Bauer TR, Hickstein DD, Russell DW.
    Hum Gene Ther; 2011 Feb 20; 22(2):217-24. PubMed ID: 20738155
    [Abstract] [Full Text] [Related]

  • 18. Lentiviral Vector-Mediated Correction of a Mouse Model of Leukocyte Adhesion Deficiency Type I.
    Leon-Rico D, Aldea M, Sanchez-Baltasar R, Mesa-Nuñez C, Record J, Burns SO, Santilli G, Thrasher AJ, Bueren JA, Almarza E.
    Hum Gene Ther; 2016 Sep 20; 27(9):668-78. PubMed ID: 27056660
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of a clinically relevant foamy vector design in human hematopoietic repopulating cells.
    Everson EM, Hocum JD, Trobridge GD.
    J Gene Med; 2018 Jul 20; 20(7-8):e3028. PubMed ID: 29935087
    [Abstract] [Full Text] [Related]

  • 20. Canine leukocyte adhesion deficiency colony for investigation of novel hematopoietic therapies.
    Creevy KE, Bauer TR, Tuschong LM, Embree LJ, Colenda L, Cogan K, Starost MF, Haskins ME, Hickstein DD.
    Vet Immunol Immunopathol; 2003 Jul 15; 94(1-2):11-22. PubMed ID: 12842608
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.